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Rhipicephalus  (Boophilus)  microplus  is  an  ectoparasite  responsible  for  an  important  decrease
in meat,  milk  and  leather  production,  caused  both  by  cattle  blood  loss  and  by the  trans-
mission  of  anaplasmosis  and  babesiosis.  R. microplus  is a rich  source  of  serine  protease
inhibitors,  including  the  trypsin  inhibitors  BmTI-A  and  BmTI-6,  the  subtilisin  inhibitor  BmSI,
and the  recently  described  thrombin  inhibitor,  boophilin.  Boophilin  is a double  Kunitz-
type  thrombin  inhibitor,  with  the  unusual  ability  to  form  a ternary  complex  with  a  second
(non-thrombin)  serine  proteinase  molecule.  The  large-scale  expression  and  puriﬁcation  of
boophilin and  of  its isolated  N-terminal  (D1)  domain  in  Pichia  pastoris,  its  expression  pro-
ﬁle,  and  the  effect  of RNAi-mediated  gene  silencing  in  tick  egg  production  are  reported.
Full-length  boophilin  and  D1  were  expressed  at 21 and  37.5  mg/L  of culture,  respectively.
Puriﬁed  boophilin  inhibited  trypsin  (Ki 0.65  nM),  neutrophil  elastase  (Ki 21  nM)  and  bovine
thrombin  (Ki 57  pM), while  D1 inhibited  trypsin  and  neutrophil  elastase  (Ki of 2.0 and
129  nM, respectively),  but  not  thrombin.  Boophilin  gene  silencing  using  RNAi  resulted  in
20% reduction  in  egg  weight  production,  suggesting  that  the  expression  of boophilin  in  this
life stage  would  be  important  but  not  vital,  probably  due  to  functional  overlap  with  other
serine  proteinase  inhibitors  in the  midgut  of R.  microplus.  Considering  our data,  Boophilin
could  be  combining  with  other  antigen  in  a vaccine  production  for  tick  control.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.. Introduction
The cattle tick Rhipicephalus (Boophilus) microplus is
idely  distributed in tropical and subtropical regions,
eing responsible for the transmission of the causative
gents of babesiosis and anaplasmosis, with a signiﬁcant
Abbreviations: D1, boophilin domain 1; D2, boophilin domain 2;
oophilin, full-length boophilin (domains 1–2).
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Open access under the Elsevier OA license.economic impact in cattle production by reducing weight
gain  and milk production (Sonenshine, 1991).
Blood sucking animals produce a considerable number
of  active molecules in their salivary glands (e.g. anticoagu-
lants, vasodilators and platelet aggregation inhibitors) that
interfere  with homeostasis in their vertebrate hosts. In par-
ticular,  these haematophagous parasites vitally depend on
blocking  the blood coagulation cascade in order to facilitate
the  acquisition and digestion of their blood meal (Ribeiro,
1995). Thrombin (or coagulation factor IIa) plays a vital role
in  blood clotting by promoting platelet aggregation and by
converting  ﬁbrinogen to ﬁbrin at the end of the pathway
(Davie et al., 1991). Thrombin is a serine protease, which
y Parasit522 T.S. Soares et al. / Veterinar
contains two  functionally important structural features,
besides the active site: the surface areas enriched in basic
residues known as exosite I (Bode et al., 1992) and exosite
II (Arni et al., 1994; Sheehan et al., 1993). As thrombin has
key roles in the intrinsic and extrinsic pathways of blood
coagulation, thrombin inhibitors are the most often iden-
tiﬁed anticoagulant molecules in blood sucking organisms
(Francischetti et al., 2008).
Among blood sucking animals, ticks are rich sources
of serine protease inhibitors, many of them belonging
to the BPTI-Kunitz family (Azzolini et al., 2003; Mans
et al., 2008; Sasaki et al., 2004), such as BmTIs (Boophilus
microplus trypsin inhibitor) from larvae and eggs, which
target trypsin, chymotrypsin, neutrophil elastase, plasma
kallikrein and plasmin (Andreotti et al., 2001, 2002; Sasaki
et al., 2004; Sasaki and Tanaka, 2008; Tanaka et al., 1999);
the tick anticoagulant peptide (TAP), a factor Xa inhibitor
from Ornithodoros moubata (Waxman et al., 1990); and
the thrombin inhibitors ornithodorin (from O. moubata
(van de et al., 1996)), savignin (from Ornithodoros savignyi
(Mans et al., 2002b)), monobin (from Argas monolakensis
(Mans and Ribeiro, 2008)) and boophilin (from R. microplus
(Macedo-Ribeiro et al., 2008)). Boophilin is a doubled-
headed Kunitz inhibitor displaying a P1 Lys residue at the
canonical reactive loop of its N-terminal Kunitz domain.
However, boophilin inhibits thrombin in a non-canonical
manner, inserting its N-terminal segment into thrombin’s
active site, while its C-terminal Kunitz domain binds to the
exosite I of the protease (Macedo-Ribeiro et al., 2008).
Given the important role of Kunitz-type inhibitors in the
R. microplus life cycle and the high speciﬁcity of boophilin
for thrombin, we expressed and puriﬁed full-length mature
boophilin and its N-terminal Kunitz domain in large scale
using a Pichia pastoris system. We  also proﬁled boophilin
gene expression and evaluated the effect of RNAi gene
silencing in tick egg production.
2. Materials and methods
2.1. Animals
R. (Boophilus) microplus (Babesia spp.-free) ticks were
supplied by Dr. Itabajara da Silva Vaz Junior (Centro de
Biotecnologia, Universidade Federal do Rio Grande do Sul,
RS, Brazil).
2.2. Materials
The pPICZB  vector and P. pastoris strain KM71H were
purchased from Invitrogen (Carlsbad, CA, USA) and used
following the supplier’s instructions. DNA sequencing
was performed using the BigDye Terminator V3.1 Cycle
Sequencing Kit on an ABI 377 or ABI 3130 sequencer
(Applied Biosystems, Foster City, CA, USA). The substrates
S2484 (Pyro-Glu-Pro-Val-pNa) and S2238 (HD-Phe-Pip-
Arg-pNa), were purchased from Chromogenix (Molndal,
Sweden) and tosyl-Gly-Pro-Arg-pNA from Sigma (Darm-
stadt, Germany). Bovine trypsin (EC 3.4.21.4) and bovine
thrombin (EC 3.4.21.5) were obtained from Sigma (St. Louis,ology 187 (2012) 521– 528
MO,  USA) and human neutrophil elastase (EC 3.4.21.37)
from Calbiochem (San Diego, CA, USA).
2.3. Quantitative Real-Time PCR
RNA from ovary, fat body, salivary gland, gut, and hemo-
cytes of engorged R. microplus adult females was extracted
using Tryzol Reagent (Invitrogen, Carlsbad, CA, USA) fol-
lowing the manufacturer’s instructions. The cDNAs were
synthesized using the ImProm-IITM Reverse Transcription
System (Promega, Madison, WI,  USA). Quantitative PCR was
performed using two speciﬁc primers designed based on
the boophilin sequence with GenBank accession number
AJ304446: Boophilinfw (5′-CAG AGA AAT GGA TTC TGC CGA
CTG CCG GCA-3′) and Boophilinrev (5′-ACA CTC CTC TAT
GGT CTC GAA-3′). R. microplus elongation factor 1-alpha
(ELF1a) speciﬁc primers – ELF1afw (5′-CGT CTA CAA GAT
TGG TGG CAT T-3′) and ELF1arv (5′-CTC AGT GGT CAG GTT
GGC AG-3′) – were used for DNA ampliﬁcation control.
Boophilin and ELF1a (endogenous control) were quanti-
ﬁed using SYBR® Green PCR Master Mix  in a 7500 Fast
Real-Time PCR System (Applied Biosystems, Foster City,
CA, USA), according to the following conditions: 40 cycles
of 95 ◦C for 1 min, 60 ◦C for 1 min and 72 ◦C for 1 min. For
each tissue, 50 ng of cDNA were used as template. All qPCR
runs were conducted in triplicate, in three independent
experiments. The amount of each mRNA was calculated
according to the 2-DDCt method (Livak and Schmittgen,
2001). ANOVA (p < 0.05) and the Tukey test were used in
the statistical analysis.
2.4. Cloning of boophilin and D1 into pPICZ˛B
The DNA fragments encoding boophilin or D1 were
ampliﬁed by PCR using a midgut cDNA preparation and
the primer set Boophifw1std (5′-GTA TCT CTC GAG AAA
AGA CAG AGA AAT GGA TTC TGC CGA CTG CCG G-3′) and
Boophirv2ndd (5′-CGA ATT AAT TCG CGG CCG CCT ACA
TGT TCT TGC AGA CGA GTT CAC AC-3′) for boophilin and
Boophifw1std and Boophirv1std (5′-CGA ATT AAT TCG CGG
CCG CCT AAG CTC CGC ACG CCT TTT GAC AAT C-3′) for D1.
PCR reactions were conducted in a ﬁnal volume of 50 L in
100 mM Tris–HCl pH 8.8, 500 mM KCl, 0.8% (v/v) Nonidet
P40, 1.5 mM MgCl2, 100 M dNTPs, 10 pM of each primer,
5 U Taq DNA polymerase with the following parameters:
94 ◦C for 2 min, prior to 30 cycles of 94 ◦C for 45 s, 55 ◦C
for 45 s and 72 ◦C for 1 min  followed by 5 min  at 72 ◦C.
Boophilin and D1 DNA fragment ampliﬁcation products
were separated by agarose gel electrophoresis and puriﬁed
using the QIAEX II gel extraction system (QIAGEN, Hilden,
Germany) according to the manufacturer’s instructions.
Puriﬁed DNA fragments were digested with XhoI and NotI
restriction enzymes, and ligated into the pPICZB  vector,
previously digested with the same enzymes, generating the
constructions Boophilin-pPICZB and D1-pPICZB, which
were veriﬁed by automated DNA sequencing.2.5. Preparation and transformation of P. pastoris yeast
P. pastoris KM71H strain was  transformed with 10 g
of SacI-linearized Boophilin-pPICZB or D1-pPICZB  by
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lectroporation in a Gene Pulser (Bio-Rad, Hercules, CA,
SA) following the manufacturer’s instructions. The eletro-
orated cells were immediately suspended in 1.0 mL  of
ce-cold 1.0 M sorbitol and spread on MD  agar plates (1.34%
east nitrogen base (YNB), 2% dextrose, 4 ×10−5% biotin)
ithout histidine. The target gene was detected in the
ecombinant P. pastoris by PCR using 3′AOX and 5′AOX
rimers (Invitrogen, Carlsbad, CA, USA). Clones that were
omologous recombinants with the AOX I sequence were
elected.
.6. Expression of recombinant Boophilin and D1
To identify positive yeast clones expressing each of
he inhibitors, six isolated P. pastoris KM71H strains car-
ying the boophilin or D1 gene fragment, identiﬁed by
CR, were individually inoculated in 2.5 mL  BMGY medium
1.0% (w/v) yeast extract, 2.0% (w/v) peptone in 100 mM
otassium phosphate buffer pH 6.0, 1.34% (w/v) YNB,
 ×10−5% (w/v) biotin and 1% (v/v) glycerol) in a 50 mL
terile tube, and grown at 30 ◦C for 28 h at 250 rpm. The
east cells were harvested by centrifugation at 3000 × g
or 5 min  at 4 ◦C and resuspended in BMMY  (BMGY with
lycerol replaced by 0.5% (v/v) methanol) medium to an
bsorbance of 1.0 at 600 nm.  Expression took place at 30 ◦C
ith shaking at 250 rpm for 4 days, with addition of 0.5%
v/v) methanol every 24 h. After removing the cells by
entrifugation (4000 × g for 20 min  at 4 ◦C), the inhibitory
ctivity of the supernatants against bovine thrombin or
ovine trypsin was assessed in activity assays using a
hromogenic substrate (S2238 or tosyl-Gly-Pro-Arg-pNA).
ndividual clones with high expression levels for boophilin
r D1 were selected (data not shown).
A single P. pastoris colony (Mut+) expressing high lev-
ls of boophilin or D1 was selected and used to inoculate
20 mL  BMGY medium in a 1 L sterile ﬂask, and incubated
t 30 ◦C and 250 rpm for 24 h. Expression was performed as
escribed above and the culture supernatant was stored at
◦C prior to puriﬁcation.
.7. Puriﬁcation of recombinant Boophilin and D1
Recombinant boophilin or D1-containing yeast culture
upernatant was loaded onto an afﬁnity trypsin-Sepharose
olumn previously equilibrated with 50 mM Tris–HCl
uffer pH 8.0 (buffer A). Weakly bound proteins were
ashed out with buffer A supplemented with 0.15 M NaCl.
he bound material was eluted with 0.5 M KCl pH 2.0 and
he collected fractions were immediately neutralized with
 M Tris–HCl buffer pH 8.0. Absorbance at 280 nm was also
onitored. The inhibitory activity of the fractions was ana-
yzed in protease activity assays (see below). The fractions
ontaining inhibitory activity and displaying one main pro-
ein band in SDS-PAGE were pooled and concentrated using
 5000 MWCO  membrane (Millipore, Billerica, MA,  USA).
.8. Determination of dissociation constant for different
erine proteasesThe concentration of active trypsin was determined
y active site titration with p-nitrophenyl-p′-guanidino-
enzoate as previously described (Chase and Shaw,ology 187 (2012) 521– 528 523
1969). The equilibrium dissociation constants of com-
plexes formed by boophilin or D1 with bovine trypsin or
neutrophil elastase were determined using the method
described by Bieth (1980).  Brieﬂy, the serine proteases
were incubated at 37 ◦C with different concentrations
of inhibitors in 0.1 M Tris–HCl buffer pH 8.0 contain-
ing 0.15 M NaCl and 0.1% Triton X-100. The residual
enzyme activity was measured after the addition of the
chromogenic substrate tosyl-Gly-Pro-Arg-pNA or elastase
substrate I (MeOSuc-Ala-Ala-Pro-Val-pNA) for trypsin and
neutrophil elastase, respectively. Apparent Ki values were
calculated by ﬁtting the steady-state velocities to the equa-
tion (Vi/Vo = 1 − {Et + It + Ki − [(Et + It + Ki)2 − 4EtIt]1/2}/2Et)
for tight-binding inhibitors and using a non-linear regres-
sion analysis (Morrison, 1969).
2.9. Thrombin inhibition assays
Boophilin (1.2 and 2.4 M)  was pre-incubated with -
thrombin (0.025 U) or -thrombin (1 g) for 10 min  at
37 ◦C in 100 mM Tris–HCl buffer pH 8.0 containing 150 mM
NaCl and 0.1% Triton X-100. The residual thrombin activity
against the ﬂuorogenic substrate Benzoyl-Phe-Val-Arg-
AMC  (200 M)  was  measured, after incubation in the same
conditions for 20 min. The ﬂuorescence was  monitored at
em = 460 nm and ex = 380 nm in a Synergy HT microplate
reader (BioTek, Winooski, VT, USA) for 20 min. As a control,
the same assay was performed in the absence of boophilin.
2.10. RNA interference
A boophilin fragment conjugated with the T7 promoter
region was  ampliﬁed by PCR using primers BoophRNAifw
(5′-GGA TCC TAA TAC GAC TCA CTA TAG GCA GAG AAA
TGG ATT CTG CCG AC-3′) and BoophRNAirv (5′-GGA TCC
TAA TAC GAC TCA CTA TAG TCA TGT TCT TGC AGA
CGA GTT CAC-3′). PCR products were puriﬁed with the
QIAEX II kit (QIAGEN, Hilden, Germany) and used as tem-
plate for double-stranded RNA (dsRNA) synthesis using
the T7 RibomaxTM Express RNAi system (Promega, Madi-
son, WI,  USA). The dsRNA was  digested with DNAse and
RNAse, precipitated with isopropanol, resuspended in ster-
ile PBS, and quantiﬁed by measuring its absorbance at
260 nm.  Engorged R. microplus females (35 individuals)
were injected with 2 L of dsRNA-boophilin (3.5 g), using
an insulin syringe. An identical control group was  injected
with 2 L of PBS buffer, and a third group was not injected.
After dsRNA injection, all groups were kept at 22–25 ◦C
and 95% humidity for 24 h, after which ten ticks of each
group were dissected and their guts placed in Trizol reagent
(Invitrogen, Carlsbad, CA, USA) for subsequent RNA extrac-
tion. Eggs of 25 ticks were collected 24 and 48 h after
injection and weighed.
2.11. Transcription analysis of boophilin gene expression
in tick gut by PCRcDNA from R. microplus engorged adult female gut was
prepared from all silencing gene expression experimental
groups using the ImProm-IITM Reverse Transcription Sys-
tem (Promega, Madison, WI,  USA). The sequence encoding
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Fig. 1. Amino acid sequence alignment of boophilin with several Kunitz-type inhibitors. Full length boophilin and D1 (this work) are compared to boophilin
variants G2 (UniProt entry Q8WPI3) and H2 (UniProt entry Q8WPI2), the thrombin inhibitors haemalin (UniProt entry B6ZIW0) from Haemaphysalis
longicornis (Liao et al., 2009), monobin (UniProt entry Q09JW6) from Argas monolakensis (Mans et al., 2008), amblin (UniProt entry Q5VJG2) from Amblyomma
hebraeum (Lai et al., 2004), ornithodorin (UniProt entry P56409) from Ornithodoros moubata (van de et al., 1996), and savignin (UniProt entry Q8WPG5)
from  Ornithodoros savignyi (Mans et al., 2002a). For comparison purposes, two molecules of BPTI (UniProt entry P00974), the bovine basic trypsin inhibitor,
are  also included. Invariant residues are displayed with a black background, while conserved amino acids are shaded gray. The residues of boophilin distinct
from  both G2 and H2 variants are highlighted in red and those where it is identical only to H2 are marked in blue. The single position where the D1 sequence
ve the al
terpretadiffers  from that of boophilin is highlighted in green. The numbering abo
2008).  Figure prepared with ALINE (Bond and Schuttelkopf, 2009). (For in
to  the web version of this article.)
boophilin was then ampliﬁed by PCR using cDNAs as tem-
plate and the speciﬁc primers Boophilinfw (5′-CAG AGA AAT
GGA TTC TGC CGA CTG CCG GCA-3′) and Boophilinrev (5′-
ACA CTC CTC TAT GGT CTC GAA-3′).
The PCR reaction (25 L) contained 1 L of cDNA sam-
ple, 25 pmol of each primer, 100 M dNTPs, 1.5 mM MgCl2,
and 2.5 U Taq DNA polymerase (Fermentas, Vilnius, Lithua-
nia) and was performed with the following parameters:
94 ◦C for 5 min, 25 cycles of 94 ◦C for 40 s, 55 ◦C for 40 s and
72 ◦C for 1 min, followed by 72 ◦C for 5 min. For DNA ampli-
ﬁcation control a similar reaction was performed using
25 pmol of R. microplus elongation factor 1-alpha (ELF1a)
speciﬁc primers: ELF1afw (5′-CGT CTA CAA GAT TGG TGG
CAT T-3′) and ELF1arv (5′-CTC AGT GGT CAG GTT GGC AG-
3′).
3. Results
3.1. Cloning, expression in P. pastoris and
characterization of recombinant boophilin
A speciﬁc tandem Kunitz domain thrombin inhibitor
from R. microplus,  named boophilin, was previouslyignment corresponds to that of mature boophilin (Macedo-Ribeiro et al.,
tion of the references to color in this ﬁgure legend, the reader is referred
described (Macedo-Ribeiro et al., 2008). In an attempt to
produce large amounts of recombinant boophilin, the DNA
fragment coding for the full-length inhibitor or for its
N-terminal domain (D1) were ampliﬁed by PCR using spe-
ciﬁc oligonucleotides based on the sequence of boophilin
variant G2 (EMBL accession code AJ304446.1) and cloned
into the P. pastoris pPICZB  expression vector. Positive
clones for boophilin and D1 were conﬁrmed by automated
DNA sequencing and used to transform P. pastoris yeast.
The sequence of cloned boophilin differed from that of
boophilin variants G2 (EMBL accession code AJ304446.1)
and H2 (EMBL accession code AJ304447.1), being closest to
the former (Fig. 1). The cloned mature boophilin was  dis-
tinct from both previously described variants at positions
27 (Gln instead of Glu) and 92 (Thr instead of Ala), and iden-
tical to variant H2 at position 66, while D1 was  identical to
variant G2 at this position. All these amino acid exchanges
occur on the solvent-exposed face of the inhibitor on its
complex with thrombin (Macedo-Ribeiro et al., 2008) and
are therefore unlikely to affect its anticoagulant activity.
Full-length boophilin and D1 were expressed in P. pas-
toris at high levels (21 and 37.5 mg/L, respectively) and
puriﬁed by afﬁnity chromatography on trypsin-Sepharose
T.S. Soares et al. / Veterinary Parasitology 187 (2012) 521– 528 525
Fig. 2. Puriﬁcation of boophilin and D1 expressed in P. pastoris yeast. (A) Afﬁnity chromatography of D1 on a trypsin-Sepharose column. Yeast supernatant
containing recombinant D1 was applied onto a trypsin-Sepharose column previously equilibrated with 0.05 M Tris–HCl buffer pH 8.0. Bound material
was  eluted with 0.5 M KCl pH 2.0. (B) Afﬁnity chromatography of boophilin on a trypsin-Sepharose column. Yeast supernatant containing recombinant
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noophilin was  puriﬁed as described for D1. (C) SDS-PAGE (15%) analysis o
ooph,  full-length boophilin (2 g); D1, N-terminal domain of boophilin (
nd  11 kDa, respectively.
Fig. 2A and B). On SDS-PAGE, puriﬁed boophilin displayed
n apparent molecular mass of 20 kDa and puriﬁed D1 of
1 kDa (Fig. 2C). The inhibitory activity of boophilin against
hrombin, trypsin and neutrophil elastase was assessed,
nd the corresponding inhibition constants (Ki) deter-
ined (Table 1). Puriﬁed boophilin showed high selectivity
o thrombin with a Ki of 57 pM,  a value signiﬁcantly
ower than the 1.80 nM reported for boophilin produced in
scherichia coli (Macedo-Ribeiro et al., 2008). The second
able 1
nhibition constants (Ki) for different serine proteases (nM).
Bovine
trypsin
Bovine
thrombin
Human
neutrophil
elastase
D1 2.00 n.i. 128.90
Boophilin 0.65 0.057 21.22
Boophilina n.d. 1.80 n.d.
.i., no inhibition; n.d., not determined.
a Macedo-Ribeiro et al. (2008).d recombinant proteins. M,  protein molecular mass standard (Bio-Rad);
oophilin and D1 display apparent molecular masses of approximately 20
Kunitz domain of boophilin displays an alanine residue at
the reactive loop P1 position (Schechter and Berger, 1967),
suggesting it could inhibit elastase. Both boophilin and D1
inhibited human neutrophil elastase in vitro with Ki val-
ues of 21 nM and 129 nM,  respectively. Boophilin inhibits
thrombin by binding simultaneously to the active site and
the exosite 1 of the protease (Macedo-Ribeiro et al., 2008).
The contribution of the interaction with the exosite 1 to the
inhibitory activity of boophilin was  probed by comparing
its activity towards -thrombin and the exosite 1-less form,
-thrombin (Fig. 3). Recombinant boophilin revealed no
activity towards -thrombin, in amounts that completely
abolished the amydolytic activity of -thrombin, therefore
underscoring the importance of the interaction with the
exosite 1.3.2. Boophilin gene expression analysis by qPCR
Different tissues of engorged R. microplus females were
dissected and used for total RNA puriﬁcation and cDNA
526 T.S. Soares et al. / Veterinary ParasitFig. 3. Inhibition of alpha and gamma-thrombin by puriﬁed recombinant
boophilin. (A) The residual activity of alpha (A) or gamma-thrombin (B)
against the ﬂuorogenic substrate Tosyl-Gly-Pro-Arg-AMC was  determined
in  the presence of different amounts of recombinant boophilin.
synthesis (Fig. 4). Boophilin gene expression was  mostly
detected in the midgut (25,000 fold above other tissues)
with minor expression levels in hemocytes, although a con-
tamination with midgut cells during dissection cannot be
discarded.
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Fig. 4. Boophilin gene expression proﬁle in different tissues of engorged
adult R. microplus females by quantitative PCR. Gut (Gut), ovary (OV),
hemocyte (Hem), salivary gland (SG) and fat body (FB) cDNA of fed ticks
were used in qPCR experiments. All data were normalized to the expres-
sion level of ELF1a (elongation factor 1-alpha), used as an internal control.
The expression level of boophilin in gut showed a signiﬁcant increase
when compared to other tissues (**p < 0.05 in Tukey’s Multiple Compari-
son Test). Error bars correspond to the standard error of the mean of three
independent experiments.ology 187 (2012) 521– 528
3.3. Boophilin gene silencing using RNA interference
In an attempt to unveil boophilin’s physiological role, a
RNAi-mediated gene silencing experiment was performed.
Three groups of ticks, each composed of 25 animals, were
injected with either boophilin dsRNA, PBS buffer or left
untreated. In comparison to the control animals, an efﬁ-
cient silencing of boophilin expression was achieved after
boophilin dsRNA treatment (Fig. 5A). Boophilin down-
regulation resulted in a decrease (∼20% after 24 and 48 h)
in egg production (Fig. 5B).
4. Discussion
Considering the important role of Kunitz-type inhibitors
in the life cycle of R. microplus and the high speciﬁcity of
the tandem Kunitz inhibitor boophilin for thrombin, full-
length boophilin and its N-terminal Kunitz domain (D1)
were expressed, puriﬁed and characterized. Furthermore,
boophilin gene expression analysis and evaluation of the
effect of RNAi silencing in egg production were also per-
formed.
Active boophilin and D1 were efﬁciently expressed in P.
pastoris and puriﬁed in a single step by afﬁnity chromatog-
raphy. Puriﬁed recombinant boophilin strongly inhibited
thrombin, with a dissociation constant in the pM range.
Moreover, it also displayed considerable activity against
trypsin (Ki 0.65 nM)  and neutrophil elastase (Ki 21 nM).
As for puriﬁed recombinant D1, it displayed an inhibitory
activity against trypsin similar to that of the full-length
inhibitor (Ki 2 nM), and also inhibited neutrophil elas-
tase, although with a signiﬁcantly decreased efﬁciency (Ki
0.129 M),  suggesting a signiﬁcant contribution from the
C-terminal Kunitz domain to this interaction, compatible
with the presence of an alanine residue in the reactive
loop P1 position. The three-dimensional structure of the
thrombin-boophilin complex revealed a bidentate inter-
action of boophilin with the active site and the exosite
I of -thrombin. The N-terminal region of the inhibitor
binds to and blocks the active site of thrombin while the
negatively charged C-terminal Kunitz domain of boophilin
docks into the basic exosite I (Macedo-Ribeiro et al., 2008).
As expected from the thrombin-boophilin complex archi-
tecture, isolated D1 does not display inhibitory activity
against thrombin, conﬁrming the fundamental contribu-
tion of the C-terminal domain-mediated interaction for
thrombin inhibition. Further highlighting the importance
of the exosite I for thrombin inhibition, boophilin inhibited
strongly -thrombin in vitro but was unable to inhibit the
exosite I-disrupted form of the enzyme, -thrombin.
In contrast to other previously described natural throm-
bin inhibitors from blood-sucking animals, boophilin may
also target additional serine proteases such as trypsin and
plasmin (Macedo-Ribeiro et al., 2008). The observed activ-
ity of boophilin against neutrophil elastase corroborated
this hypothesis, suggesting a role other than counteracting
blood coagulation in the midgut of R. microplus.  Blood is
a complex mixture of numerous soluble proteins, includ-
ing plasmin precursor plasminogen, and of different cells,
among which the elastase-producing neutrophils. In ticks,
blood digestion lasts for several days, during and after the
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Fig. 5. (A) Boophilin expression in R. microplus gut after gene silencing. (a) Ticks injected with boophilin dsRNA, each line represents the gut of one tick,
showing that the silencing was efﬁcient. Results of two independent experiments (only one was  shown); (b) ticks injected with PBS buffer and (c) non-
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pnjected ticks. (B) Reduction in oviposition after RNAi-silencing of boophil
ith  ds-boophilin showed 20% of oviposition reduction compared to non-in
eviation.
ngorgement process, and it is therefore conceivable that
oophilin might be used to control any plasmin or elas-
ase activity arising in the midgut during this period, even
hen complexed with thrombin, avoiding unwanted tissue
amage.
Boophilin amino acid sequence is 37% identical to
hat of hemalin (Liao et al., 2009), a thrombin inhibitor
escribed in the tick Haemaphysalis longicornis.  However,
hile hemalin was expressed in all major tissues (including
alivary glands, midgut, hemocytes and fat body) of adult
emale ticks, boophilin was exclusively expressed in the
idgut, suggesting an important role in this organ. Con-
idering its limited expression and its multiple inhibitory
ctivities, silencing of boophilin expression was expected
o impact serine protease activity levels in the midgut and
onsequently the digestion process, with a visible effect in
gg production. Injection of dsRNA-boophilin in engorged
. microplus females almost abolished boophilin transcrip-
ion in the midgut and resulted in 20% reduction in egg
roduction, a result similar to that observed for hemalinnjected with PBS showed 5% of oviposition reduction while ticks injected
icks. The results are the mean of two independent experiments ± standard
gene silencing (Liao et al., 2009). A possible explanation
for the apparently small impact of boophilin gene silenc-
ing in egg production might be the vast array of Kunitz
type inhibitors present in R. microplus,  which were not
observed in the related Rhipicephalus sanguineus (Azzolini
et al., 2003). Besides boophilin, R. microplus produces other
Kunitz type inhibitors with activity against trypsin, plas-
min, plasma kallikrein and neutrophil elastase (Sasaki et al.,
2004; Sasaki and Tanaka, 2008; Tanaka et al., 1999). Inter-
estingly, some of these inhibitor genes are highly expressed
in R. microplus midgut, and could partially make up for
boophilin decrease in the dsRNA-boophilin injected ticks,
leading to a lower impact in egg production. Similar results
were obtained when other Kunitz type inhibitors were
silenced or anti-BmTIs were injected in engorged females
(A.S. Tanaka, unpublished data). The present ﬁndings, as
well as the presence of another thrombin inhibitor in the
midgut of R. microplus (Ricci et al., 2007), highlight the high
redundancy of R. microplus Kunitz-based serine protease
inhibitor arsenal, which certainly contributes to its evident
y Parasit
key to the TAP enigma? Immunopharmacology 15, 6011–6017.528 T.S. Soares et al. / Veterinar
efﬁciency as a bovine ectoparasite. Considering our data,
and the redundancy of R. microplus Kunitz inhibitors we
believe that boophilin may  be useful as an antigen together
with other tick protein in a vaccine production for tick con-
trol.
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